Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Will COINS Act kill China biotech licensing boom?
Amid China’s rapid biotech ascent, a growing chorus in the U.S. wants biotechnology added to the COINS Act to restrict outbound capital flows.
Angus Liu
May 26, 2026 3:50pm
Kardigan itching for IPO to fund late-stage cardio pipeline
May 27, 2026 4:57am
FDA delays ruling on AstraZeneca drug after negative adcomm vote
May 27, 2026 4:43am
Apogee bags $1.3B royalty funding deal to advance eczema hopeful
May 27, 2026 8:57am
Kordata launches with neural-focused AI clinical trial model
May 27, 2026 12:50pm
D&D sees fibrosis improvements, MASH resolution on GLP-1 drug
May 27, 2026 10:30am
More News
Olympus pushes deeper into oncology with $270M BioProtect deal
May 26, 2026 3:57pm
Makary FDA reforms ‘continue to move forward’ despite turmoil
May 26, 2026 10:27am
Kura posts data on drug designed to unleash KRAS inhibitors
May 26, 2026 10:09am
Lilly inks deals to buy 3 vaccine developers for up to $3.8B
May 26, 2026 7:57am
See more stories